Clinical Trials Directory

Trials / Completed

CompletedNCT02909244

Study of Gut Microbiota in Primary Immune Deficiency, Possibly Associated With Inflammatory Bowel Disease

Study of Gut Microbiota in Primary Immune Deficiencies, Possibly Associated With Inflammatory Bowel Disease (Chronic Granulomatous Disease, XIAP Gene Deficiency, or TTC7A Gene Deficiency)

Status
Completed
Phase
Study type
Observational
Enrollment
51 (actual)
Sponsor
Imagine Institute · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Some Primary Immune Deficiencies can be associated with an inflammatory bowel disease, mimicking Crohn disease : the Chronic Granulomatous Disease (CGD), the XIAP deficiency, and the TTC7A deficiency. This inflammatory bowel disease is frequent but inconstant, raising questions about other factors contributing to the disease. The aim of our study is to analyze, describe and compare the gut microbiota of patients with those primary immune deficiency, with or without intestinal disease. The investigators can expect, in the long term, to compare on a same patient, the gut microbiota evolution, and to assess the role of gut microbiota modifications on the onset of an inflammatory bowel disease.

Detailed description

The investigators will include patients (adults or children), with Primary Immune Deficiency (CGD, XIAP or TTC7A deficiencies), and they will collect feces samples from them. In parallel, as control groups, patients with no inflammatory bowel disease and no primary immune deficiency will be included, and also patients suffering from Crohn's disease without known primary immune deficiency. The laboratory collaborators will then realize analyzes on the microbiota collected for all patients. The study team will then analyze the microbiota composition of the different types of patients, and try to identify some factors, associated with the appearance of an inflammatory disease on these patients.

Conditions

Interventions

TypeNameDescription
BIOLOGICALBiological samplingBiological sampling

Timeline

Start date
2015-02-01
Primary completion
2017-02-01
Completion
2017-02-01
First posted
2016-09-21
Last updated
2017-08-25

Locations

3 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02909244. Inclusion in this directory is not an endorsement.